Literature DB >> 17341579

Diabetes and the risk of osteonecrosis of the jaw.

Murray J Favus.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17341579     DOI: 10.1210/jc.2007-0098

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  5 in total

1.  Bisphosphonate-associated osteonecrosis of the jaw.

Authors:  Aliya Khan
Journal:  Can Fam Physician       Date:  2008-07       Impact factor: 3.275

Review 2.  NF-κB as a Therapeutic Target in Inflammatory-Associated Bone Diseases.

Authors:  T-H Lin; J Pajarinen; L Lu; A Nabeshima; L A Cordova; Z Yao; S B Goodman
Journal:  Adv Protein Chem Struct Biol       Date:  2016-12-09       Impact factor: 3.507

Review 3.  Targeted Delivery Systems for Molecular Therapy in Skeletal Disorders.

Authors:  Lei Dang; Jin Liu; Fangfei Li; Luyao Wang; Defang Li; Baosheng Guo; Xiaojuan He; Feng Jiang; Chao Liang; Biao Liu; Shaikh Atik Badshah; Bing He; Jun Lu; Cheng Lu; Aiping Lu; Ge Zhang
Journal:  Int J Mol Sci       Date:  2016-03-22       Impact factor: 5.923

4.  Evaluation of the predisposing factors and involved outcome of surgical treatment in bisphosphonate-related osteonecrosis of the jaw cases including bone biopsies.

Authors:  Tae-Hwan Kim; Won-Gyo Seo; Chul-Hong Koo; Jae-Hoon Lee
Journal:  J Korean Assoc Oral Maxillofac Surg       Date:  2016-08-24

Review 5.  Non-Viral Delivery System and Targeted Bone Disease Therapy.

Authors:  Abdul Qadir; Yongguang Gao; Patil Suryaji; Ye Tian; Xiao Lin; Kai Dang; Shanfeng Jiang; Yu Li; Zhiping Miao; Airong Qian
Journal:  Int J Mol Sci       Date:  2019-01-29       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.